Belantamab mafodotin (Belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study Meeting Abstract
| Authors: | Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Kotowsky, N.; Bitetti, J.; Mackay, C.; Boytsov, N.; Camadoo-O'Byrne, L.; Germain, G.; Duh, M. S.; Laliberté, F.; Mahendran, M.; Urosevic, A.; Lee, H. C. |
| Abstract Title: | Belantamab mafodotin (Belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 10124 |
| End Page: | 10126 |
| Language: | English |
| ACCESSION: | WOS:000893230303061 |
| DOI: | 10.1182/blood-2022-164929 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
